A nationwide recall of more than 3.1 million bottles of eye drops has been issued in the United States, affecting products sold at major retailers including Walgreens, CVS, and Kroger. The recall stems from concerns about manufacturing conditions that may have compromised product sterility.
The products, manufactured by California-based K.C. Pharmaceuticals, were distributed under multiple brand names and private labels. Health authorities say the issue does not necessarily confirm contamination, but reflects a failure to guarantee that the products were produced in sterile conditions.
Manufacturing Concerns Prompt Nationwide Recall across Multiple Brands
The recall was voluntarily initiated on March 3 by K.C. Pharmaceuticals and later classified as a Class II recall by the U.S. Food and Drug Administration. This classification indicates that use of the affected products may cause temporary or medically reversible health effects, with serious consequences considered unlikely.
According to the FDA, the recall involves a “lack of assurance of sterility,” meaning the manufacturing process could not confirm that the eye drops were free from potential microbial contamination. This distinction is central: regulators have not stated that contamination has been detected, only that safety standards were not fully met.
The scope of the recall is significant. According to CBS News, the largest affected batch includes more than 1 million bottles of Dry Eye Relief Eye Drops. Other impacted products include Artificial Tears Sterile Lubricant Eye Drops, Sterile Eye Drops Original Formula, and Eye Drops Advanced Relief, among several others.
These products were sold widely through national pharmacy chains, supermarkets, and distributors. Retailers include Walgreens, CVS, Rite Aid, Kroger, H-E-B, Publix, and Dollar General, as well as various wholesale and private-label brands. According to FOX 11, the recall spans dozens of labels, many of them store-brand versions of common eye care products. Most of the recalled items are 0.5 fluid ounce bottles, with expiration dates extending into mid to late 2026.
No Confirmed Injuries, but Consumers Advised to Take Precautions
At this stage, there have been no confirmed reports of adverse health effects linked to the recalled eye drops. Still, health officials are advising consumers to stop using the products immediately as a precaution.
According to NBC New York, the FDA has not reported any confirmed infections or injuries tied to the recall. The agency’s classification reflects a relatively low level of risk, though it still warrants attention due to the potential for eye exposure to non-sterile solutions.
Consumers are encouraged to check product labels and lot numbers carefully. Specific lot codes associated with the recall reportedly begin with combinations such as AC, AR, LT, SU, RG, RL, SY, or AT, and are tied to expiration dates in 2026. Products matching these details should be set aside and not used.
Health guidance remains straightforward. According to FOX 11, individuals who have used the recalled eye drops and experience symptoms such as eye irritation, redness, pain, or changes in vision should seek medical advice promptly. The FDA has not yet issued detailed instructions regarding refunds or replacements. In practice, returns may depend on individual retailer policies, though large pharmacy chains often accommodate recalls of this nature.
